{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T10:00:07Z","timestamp":1784973607561,"version":"3.55.0"},"update-to":[{"DOI":"10.1002\/14651858.cd009227","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000}}],"reference-count":58,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009227.pub2","type":"journal-article","created":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T14:35:48Z","timestamp":1409582148000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophrenia"],"prefix":"10.1002","volume":"2014","author":[{"given":"Magdolna","family":"Tardy","sequence":"first","affiliation":[{"name":"Technische Universit\u00e4t M\u00fcnchen Klinikum rechts der Isar; Klinik und Poliklinik f\u00fcr Psychiatrie und Psychotherapie; M\u00f6hlstr. 26 M\u00fcnchen Germany 81675"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Dold","sequence":"additional","affiliation":[{"name":"Technische Universit\u00e4t M\u00fcnchen Klinikum rechts der Isar; Klinik und Poliklinik f\u00fcr Psychiatrie und Psychotherapie; M\u00f6hlstr. 26 M\u00fcnchen Germany 81675"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf R","family":"Engel","sequence":"additional","affiliation":[{"name":"Ludwig-Maximilians-University Munich; Psychiatric Hospital; Nussbaumstr. 7 Muenchen Germany 80336"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Leucht","sequence":"additional","affiliation":[{"name":"Technische Universit\u00e4t M\u00fcnchen; Department of Psychiatry and Psychotherapy; Ismaningerstrasse 22 M\u00fcnchen Germany 81675"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,9,1]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD009227.pub2-BIB0001|cit1","first-page":"117","article-title":"A comparative study of fluanxol and chlorpromazine used for schizophrenia","volume":"21","author":"Liu","year":"2000","journal-title":"Journal of Taishan Medical College"},{"issue":"2","key":"10.1002\/14651858.CD009227.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1192\/bjp.148.2.120","article-title":"A randomised controlled trial of prophylactic neuroleptic treatment","volume":"148","author":"Crow","year":"1986","journal-title":"British Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD009227.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1192\/bjp.148.2.115","article-title":"The Northwick Park study of first episodes of schizophrenia. I. Presentation of the illness and problems relating to admission","volume":"148","author":"Johnstone","year":"1986","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0004|cit4","unstructured":"Johnstone EC Owens DGC Does early treatment have an effect on outcome? Proceedings of the 10th European College of Neuropsychopharmacology Congress; 1997 Sep 13-17; Vienna, Austria 1997"},{"issue":"2","key":"10.1002\/14651858.CD009227.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1192\/bjp.148.2.128","article-title":"Short-term outcome in trial entrants and trial eligible patients","volume":"148","author":"MacMillan","year":"1986","journal-title":"British Journal of Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD009227.pub2-BIB0006|cit6","first-page":"739","article-title":"Clinical evaluation on effect of flupentixol, a neuroleptic drug, on schizophrenia by double-blind controlled trial","volume":"13","author":"Ishimaru","year":"1971","journal-title":"Seishin Igaku (Clinical Psychiatry)"},{"issue":"8069","key":"10.1002\/14651858.CD009227.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0140-6736(78)90193-9","article-title":"Mechanism of the antipsychotic effect in the treatment of acute schizophrenia","volume":"1","author":"Johnstone","year":"1978","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD009227.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF00427342","article-title":"3-methoxy-4-hydroxyphenylglycol excretion in acutely schizophrenic patients during a controlled clinical trial of the isomers of flupenthixol","volume":"64","author":"Joseph","year":"1979","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0009|cit9","unstructured":"Adams CE Coutinho E Davis JM Cochrane Schizophrenia Group The Cochrane Library 2008"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.biopsych.2009.08.040","article-title":"Antipsychotic drug equivalents and dose-years: a standardized method for comparing exposure to different drugs","volume":"67","author":"Andreasen","year":"2010","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0011|cit11","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890423349","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV-TR)","author":"American Psychistric Association","year":"2000"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0012|cit12","volume-title":"Psychische Erkrankungen. Klinik und Therapie","author":"Berger","year":"2003"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Statistics notes. Trials randomised in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD009227.pub2-BIB0014|cit14","first-page":"405","article-title":"The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use","volume":"54","author":"Boissel","year":"1999","journal-title":"Therapie"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/135581960000500105","article-title":"Sample size calculations for cluster randomised trials. Changing Professional Practice in Europe Group (EU BIOMED II Concerted Action)","volume":"5","author":"Campbell","year":"2000","journal-title":"Journal of Health Services Research and Policy"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1056\/NEJM199403103301006","article-title":"Schizophrenia","volume":"330","author":"Carpenter","year":"1994","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD009227.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1176\/ajp.132.12.1237","article-title":"Overview: maintenance therapy in psychiatry: I. Schizophrenia","volume":"132","author":"Davis","year":"1975","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0018|cit18","article-title":"Antipsychotic drugs","volume-title":"Comprehensive Textbook of Psychiatry","author":"Davis","year":"1989"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0019|cit19","unstructured":"Deeks J Issues in the selection for meta-analyses of binary data Proceedings of the 8th International Cochrane Colloquium; 2000 Oct 25-28th; Cape Town, South Africa Cape Town 2000"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"Der-Simonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD009227.pub2-BIB0022|cit22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009831","article-title":"Haloperidol versus first generation antipsychotics for schizophrenia","author":"Dold","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"13","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/15622970510030090","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) - Guidelines for biological treatment of schizophrenia, part 1: Acute treatment of schizophrenia","volume":"6","author":"Falkai","year":"2005","journal-title":"World Journal of Biological Psychiatry"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0026|cit26","volume-title":"Behandlungsleitlinie Schizophrenie","author":"Gaebel","year":"2006"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994","volume":"149","author":"Gulliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0028|cit28","volume-title":"Dosierung der Neuroleptika. Ein Leitfaden F\u00fcr Klinik Und Praxis Unter Besonderer Ber\u00fccksichtigung Psychotisch Kranker","author":"Haase","year":"1983"},{"issue":"1","key":"10.1002\/14651858.CD009227.pub2-BIB0029|cit29","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003443.pub2","article-title":"Perphenazine for schizophrenia","author":"Hartung","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0030|cit30","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.63.10.1079","article-title":"Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia - cost utility of the latest antipsychotic drugs in schizophrenia study (CUtLASS 1)","volume":"63","author":"Jones","year":"2006","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0032|cit32","volume-title":"Positive and Negative Syndrome Scale (PANSS) Manual","author":"Kay","year":"1986"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF00433814","article-title":"Concentrations of Cis(Z)-flupentixol in maternal serum, amniotic fluid, umbilical cord serum, and milk","volume":"72","author":"Kirk","year":"1980","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0034|cit34","volume-title":"Diagnosis and Drug Treatment of Psychiatric Disorders","author":"Klein","year":"1969"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0035|cit35","first-page":"1","article-title":"Practice guideline for the treatment of patients with schizophrenia, second edition","volume":"161","author":"Lehman","year":"2004","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.biopsych.2005.10.020","article-title":"Attrition in randomized controlled clinical trials: methodological issues in psychopharmacology","volume":"59","author":"Leon","year":"2006","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","article-title":"What does the PANSS mean?","volume":"79","author":"Leucht","year":"2005","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","article-title":"What does the PANSS mean?","volume":"79","author":"Leucht","year":"2005","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","article-title":"A meta-analysis comparing second-generation and first-generation antipsychotics for schizophrenia","volume":"373","author":"Leucht","year":"2009","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0041|cit41","first-page":"820","article-title":"Psychotropic Drugs","volume-title":"Arzneimittelverordnungsreport","author":"Lohse","year":"2005"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00127-004-0762-4","article-title":"Schizophrenia and employment: a review","volume":"39","author":"Marvaha","year":"2004","journal-title":"Social Psychiatry and Psychiatric Epidemiology"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"c869","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD009227.pub2-BIB0045|cit45","first-page":"714","article-title":"Special feature: rating scales and assessment instruments for use in pediatric psychopharmacology research","volume":"21","author":"National Institute of Mental Health","year":"1985","journal-title":"Psychopharmacological Bulletin"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/9780470712184.ch12","article-title":"Chapter 12: Interpreting results and drawing conclusions","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Sch\u00fcnemann","year":"2008"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1126\/science.1145194","article-title":"Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons","volume":"188","author":"Seeman","year":"1975","journal-title":"Science"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0049|cit49","doi-asserted-by":"crossref","unstructured":"Shen X Xia J Adams Clive E Flupenthixol versus placebo for schizophrenia Cochrane Database of Systematic Reviews 2012 10.1002\/14651858.CD009777.pub2","DOI":"10.1002\/14651858.CD009777.pub2"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side-effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"issue":"2","key":"10.1002\/14651858.CD009227.pub2-BIB0051|cit51","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001944","article-title":"Thioridazine for schizophrenia","author":"Sultana","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD009227.pub2-BIB0052|cit52","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009369","article-title":"Perphenazine versus low-potency first generation antipsychotic drugs for schizophrenia","author":"Tardy","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD009227.pub2-BIB0053|cit53","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009230","article-title":"Fluphenazine versus low-potency first generation antipsychotic drugs for schizophrenia","author":"Tardy","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD009227.pub2-BIB0054|cit54","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009396","article-title":"Trifluoperazine versus low-potency first generation antipsychotic drugs for schizophrenia","author":"Tardy","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD009227.pub2-BIB0055|cit55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009268","article-title":"Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia","author":"Tardy","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD009227.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jclinepi.2004.02.018","article-title":"Effect sizes in cumulative meta-analyses of mental health randomized trials evolved over time","volume":"57","author":"Trikalinos","year":"2004","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/archpsyc.1978.01770260031002","article-title":"Suicide in schizophrenics, manics, depressives, and surgical controls: a comparison with general population suicide mortality","volume":"35","author":"Tsuang","year":"1978","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD009227.pub2-BIB0058|cit58","unstructured":"Xia J Adams CE Bhagat N Bhagat V Bhoopathi P El-Sayeh H The Leeds Outcomes Stakeholders Survey (LOSS) Study Proceedings of the 15th Cochrane Colloquium;Oct 23-27; Sao Paulo 2007"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD009227.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T15:33:36Z","timestamp":1702913616000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009227.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Schizophrenia Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,9,1]]},"references-count":58,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009227.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,1]]}}}